Corporate Responsibility Report
MESSAGE FROM OUR CEO
Dear Associates and Investors,
We are pleased to present to you and the public, our 2019-2020 Corporate Responsibility Report. At Medpace, our mission is to accelerate the global development of safe and effective medical therapeutics. We pursue our mission through responsibly managing our company and promoting an environment where our most valuable assets, our people, will thrive. This requires we be sensitive to the needs of our associates, as well as all our support partners and vendors, the patients we care for, and the communities in which we operate and all our stakeholders lives. Our view of corporate responsibility revolves around prioritizing ethical behavior in all we do, from our approach to executing clinical trials, to our interactions with our sponsors and investors, to the way we interact with the world around us. We have taken a comprehensive approach to corporate responsibility, not only doing what is expected or required of us as a corporate citizen under the laws and regulations with which we must comply, but also looking beyond the mere requirements and assessing what is the right thing to do to advance our mission. That is an important part of why our associates have chosen to work for us, and why our investors have capitalized us because our success is tied to our mission and our mission is enhanced by operating in an honest, ethical and conscientious manner.
August J. Troendle